Merck Animal Health agreed to acquire Vence Corp from a consortium of shareholders on September 22, 2022. The transaction is expected to close in the third quarter of 2022, subject to customary closing conditions.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2,858 GBX | -0.50% | -1.55% | +11.16% |
11:52am | Shell in talks to sell Malaysia fuel stations to Saudi Aramco, sources say | RE |
07:50am | Shell Registers Deceptive Carbon Credits Under Canadian Subsidy Scheme | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+11.16% | 229B | |
-9.09% | 1,936B | |
+16.02% | 457B | |
+38.76% | 249B | |
+9.29% | 166B | |
+7.12% | 105B | |
-6.15% | 80.36B | |
-.--% | 51.18B | |
+23.11% | 49.16B | |
+26.95% | 38.11B |
- Stock Market
- Equities
- SHEL Stock
- News Shell plc
- Merck Animal Health agreed to acquire Vence Corp from a consortium of shareholders.